Main Content


Publication archives


  • Bates EA, Kipp ZA, Martinez GJ, Badmus OO, Soundarapandian MM, Foster D, Xu M, Creeden JF, Greer JR, Morris AJ, Stec DE, Hinds TD Jr. Suppressing hepatic UGT1A1 increases plasma bilirubin, lowers plasma urobilin, reorganizes kinase signaling pathways and lipid species and improves fatty liver disease. Biomolecules. 2023 Jan 29;13(2):252. doi: 10.3390/biom13020252. PMID: 36830621; PMCID: PMC9953728.
  • Bhattarai U, He X, Xu R, Liu X, Pan L, Sun Y, Chen JX, Chen Y. IL-12α deficiency attenuates pressure overload-induced cardiac inflammation, hypertrophy, dysfunction, and heart failure progression. Front Immunol. 2023 Feb 13;14:1105664. doi: 10.3389/fimmu.2023.1105664. PMID: 36860846; PMCID: PMC9969090.
  • Flack KD, Vítek L, Fry CS, Stec DE, Hinds TD Jr. Cutting edge concepts: Does bilirubin enhance exercise performance? Front Sports Act Living. 2023 Jan 11;4:1040687. doi: 10.3389/fspor.2022.1040687. PMID: 36713945; PMCID: PMC9874874.
  • Hamid A, Yimer WK, Oshunbade AA, Kamimura D, Clark D 3rd, Fox ER, Min YI, Muntner P, Shimbo D, Pandey A, Shah AM, Mentz RJ, Jones DW, Bertoni AG, Hall JE, Correa A, Butler J, Hall ME. Impact of diabetes and hypertension on left ventricular structure and function: the jackson heart study. J Am Heart Assoc. 2023 Mar 7:e026463. doi: 10.1161/JAHA.122.026463. Epub ahead of print. PMID: 36880997.
  • Han H, Ma R, Xie A, Gao J, Wang Z, Zhao Y, Pang H, Zhang W. Development of an LC/MS/MS method for simultaneous detection of 11 polyphenols in rat plasma and its pharmacokinetic application after oral administration of coreopsis tinctoria extract. Chem Biodivers. 2023 Jan;20(1):e202200574. doi: 10.1002/cbdv.202200574. Epub 2022 Dec 7. PMID: 36382445.
  • Hinds TD Jr, Stec DE, Tiribelli C. Powering the powerhouse: heme oxygenase-1 regulates mitochondrial function in non-alcoholic fatty liver disease (NAFLD). Acta Physiol (Oxf). 2023 Mar;237(3):e13931. doi: 10.1111/apha.13931. Epub 2023 Jan 18. PMID: 36622267.
  • Kipp ZA, Martinez GJ, Bates EA, Maharramov AB, Flight RM, Moseley HNB, Morris AJ, Stec DE, Hinds TD Jr. Bilirubin nanoparticle treatment in obese mice inhibits hepatic ceramide production and remodels liver fat content. Metabolites. 2023 Feb 1;13(2):215. doi: 10.3390/metabo13020215. PMID: 36837834; PMCID: PMC9965094.
  • Mallette JH, Crudup B, Alexander BT. Growth restriction in preeclampsia: lessons from animal models. Science Direct. Volume 32,2023,100647; ISSN 2468-8673.
  • Martin BE, Taylor EB, Attipoe EM, Wu W, Stec DE, Showmaker KC, Garrett MR. Sex and molecular differences in cardiovascular parameters at peak influenza disease in mice. Physiol Genomics. 2023 Jan 16. doi: 10.1152/physiolgenomics.00146.2022. Epub ahead of print. PMID: 36645670.
  • Rivera-Gonzalez O, Case CT, Wilson NA, Speed JS, Taylor EB. Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosus. Am J Physiol Endocrinol Metab. 2023 Jan 1;324(1):E73-E84. doi: 10.1152/ajpendo.00274.2022. Epub 2022 Dec 7. PMID: 36476039; PMCID: PMC9870584.
  • Vitek L, Hinds TD Jr, Stec DE, Tiribelli C. The physiology of bilirubin: health and disease equilibrium. Trends Mol Med. 2023 Feb 22:S1471-4914(23)00031-X. doi: 10.1016/j.molmed.2023.01.007. Epub ahead of print. PMID: 36828710.
  • Wang Z, Hu S, Wu X, He Z, Ke C, Hu M. A highly sensitive LC-MS/MS method for the determination and quantification of a recently identified N-nitrosamine impurity in the sitagliptin phosphate monohydrate active pharmaceutical ingredient. Anal Methods. 2023 Jan 19;15(3):256-260. doi: 10.1039/d2ay01821g. PMID: 36598084.